Skip to content
10-K

Annual Report

NURIX THERAPEUTICS, INC. NRIX

0001549595-26-000016

← back to feed
Filed
Jan 28, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Jan 23, 2026 102.84M sh
Shares Diluted FY 2025 · Nov 30, 2025 86.67M sh
Shares Diluted FY 2025 · Nov 30, 2024 67.12M sh
Shares Diluted FY 2025 · Nov 30, 2023 54.34M sh
Capex FY 2025 · Nov 30, 2025 $14M
Capex FY 2025 · Nov 30, 2024 $9.27M
Capex FY 2025 · Nov 30, 2023 $8.4M
Operating Cash Flow FY 2025 · Nov 30, 2025 −$249.47M
Operating Cash Flow FY 2025 · Nov 30, 2024 −$172.58M
Operating Cash Flow FY 2025 · Nov 30, 2023 −$81.37M
Cash And Equivalents FY 2025 · Nov 30, 2025 $246.96M
Cash And Equivalents FY 2025 · Nov 30, 2024 $110M
Cash And Equivalents FY 2025 · Nov 30, 2023 $54.63M
Stockholders Equity FY 2025 · Nov 30, 2025 $538.75M
Stockholders Equity FY 2025 · Nov 30, 2024 $526.99M
Stockholders Equity FY 2025 · Nov 30, 2023 $200.49M
Stockholders Equity FY 2025 · Nov 30, 2022 $303.7M
Current Liabilities FY 2025 · Nov 30, 2025 $86.47M
Current Liabilities FY 2025 · Nov 30, 2024 $95.85M
Total Liabilities FY 2025 · Nov 30, 2025 $149.39M
Total Liabilities FY 2025 · Nov 30, 2024 $142.35M
Current Assets FY 2025 · Nov 30, 2025 $606.82M
Current Assets FY 2025 · Nov 30, 2024 $619.39M
Total Assets FY 2025 · Nov 30, 2025 $688.14M
Total Assets FY 2025 · Nov 30, 2024 $669.34M
Eps Diluted FY 2025 · Nov 30, 2025 −$3.05
Eps Diluted FY 2025 · Nov 30, 2024 −$2.88
Eps Diluted FY 2025 · Nov 30, 2023 −$2.65
Eps Basic FY 2025 · Nov 30, 2025 −$3.05
Eps Basic FY 2025 · Nov 30, 2024 −$2.88
Eps Basic FY 2025 · Nov 30, 2023 −$2.65
Sga Expense FY 2025 · Nov 30, 2025 $52.74M
Sga Expense FY 2025 · Nov 30, 2024 $45.94M
Sga Expense FY 2025 · Nov 30, 2023 $42.9M
Rd Expense FY 2025 · Nov 30, 2025 $316.9M
Rd Expense FY 2025 · Nov 30, 2024 $221.63M
Rd Expense FY 2025 · Nov 30, 2023 $189.15M
Net Income FY 2025 · Nov 30, 2025 −$264.46M
Net Income FY 2025 · Nov 30, 2024 −$193.57M
Net Income FY 2025 · Nov 30, 2023 −$143.95M
Operating Income FY 2025 · Nov 30, 2025 −$285.67M
Operating Income FY 2025 · Nov 30, 2024 −$213.03M
Operating Income FY 2025 · Nov 30, 2023 −$155.06M
Revenue FY 2025 · Nov 30, 2025 $83.98M
Revenue FY 2025 · Nov 30, 2024 $54.55M
Revenue FY 2025 · Nov 30, 2023 $76.99M